Considering that TMZ-resistant T98G cells were more sensitive to the PDIA3 inhibition, we determined the adjuvant action of PDIA3 inhibition on the treatment of glioblastoma with the chemotherapy agent TMZ. This evidence concerns the gene PDIA3 and glioblastoma.